A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support

Hematopoietic stem cell transplantation following myeloablative chemotherapy is a curative treatment for many hematopoietic malignancies. However, profound granulocytopenia during the interval between transplantation and marrow recovery exposes recipients to risks of fatal infection, a significant s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Desai, Amar, Zhang, Yongyou, Park, Youngsoo, Dawson, Dawn M., Larusch, Gretchen A., Kasturi, Lakshmi, Wald, David, Ready, Joseph M., Gerson, Stanton L., Markowitz, Sanford D.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058768/
https://ncbi.nlm.nih.gov/pubmed/29472361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.178376
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados